ArticleHaematologica2019
Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses.
Abstract readLetter
In one paragraph
Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin.Virchows Archiv : an international journal of pathology · 2022Pooled it
- SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities.Cancer discovery · 2026Article
- Decoding IGLL5 Mutation-Mediated BCR Signaling: A Novel Mechanism of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroups.HemaSphere · 2026Article
- Rare Presentation of Sequential Mucosa-Associated Lymphoid Tissue Lymphoma, Follicular Lymphoma, and Chronic Lymphocytic Leukemia: A Case-Based Review.Journal of community hospital internal medicine perspectives · 2026Article
- Artificial Intelligence in Hematologic Malignancies: Opportunities, Challenges, and Clinical Integration.Cureus · 2026Review
- Clinical utility of repeated IgH gene rearrangement testing for the diagnosis and surveillance of gastric MALT lymphoma.Scientific reports · 2025Article
- Molecular profiling of primary renal marginal zone lymphoma reveals overlapping features with extranodal marginal zone lymphoma.Blood advances · 2025Article
- Mucosal healing of ileum-mucosa-associated lymphoid tissue lymphoma afterFrontiers in oncology · 2025Article
- Investigating the frequency of somatic MYD88 L265P mutation in primary ocular adnexal B cell lymphoma.Molecular biology reports · 2024Article
- Imaging Flow Cytometry: Development, Present Applications, and Future Challenges.Methods and protocols · 2024Review
- Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.Hematological oncology · 2023Article
- Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma.Expert review of hematology · 2023Review
- Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.Scientific reports · 2023Article
- Lymphoma-associated mutations in autoreactive memory B cells of patients with Sjögren's syndrome.The Journal of pathology · 2023Article
- Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors.Journal of clinical medicine · 2023Article
- Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal.Therapeutic advances in medical oncology · 2023Review
- A roadmap for clinical trial design in marginal zone lymphoma.American journal of hematology · 2022Article
- Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022Article
- The EHA Research Roadmap: Malignant Lymphoid Diseases.HemaSphere · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Luciano CascioneUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Andrea RinaldiUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Alessio BruscagginUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Chiara TarantelliUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Alberto J ArribasUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Ivo KweeUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Lorenza PecciariniSan Raffaele Scientific Institute, Milan, Italy.
Afua A MensahUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Valeria SpinaUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Elaine Y L ChungUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Lodovico Terzi di BergamoUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Stephan DirnhoferInstitute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland.
Alexandar TzankovInstitute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland.
Roberto N MirandaDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ken H YoungDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Alexandra Traverse-GlehenAnatomie-pathologique, Hospices Civils de Lyon Centre, Lyon, France.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
Steven H SwerdlowDivision of Hematopathology, UPMC Presbyterian, Pittsburgh, PA, USA.
Randy GascoyneBritish Columbia Cancer Agency, Vancouver, BC, Canada.
Raul RabadanDepartment of Systems Biology, Department of Biomedical Informatics, Columbia University College of Physicians & Surgeons, New York, NY, USA.
Maurilio PonzoniSan Raffaele Scientific Institute, Milan, Italy.
Govind BhagatDepartment of Pathology and Cell Biology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA.
Davide RossiUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Emanuele ZuccaOncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Francesco BertoniUniversità della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland frbertoni@mac.com.
Funding
Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3MNCI NIH HHS P30 CA013696
Abstract
PubMed holds no abstract for this paper.
Indexed as
Epigenesis, GeneticGene Expression Regulation, NeoplasticBiomarkers, TumorHigh-Throughput Nucleotide SequencingHumansLymphoma, B-Cell, Marginal ZonePrognosisBiomarkers, Tumor
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.